IP Verse

Alkermes Pharma Ireland competitive analysis

Latest publications and patents of Alkermes Pharma Ireland New

Explore the latest publications and patents granted to Alkermes Pharma Ireland, showcasing their recent innovations and technological advancements.

Last updated on: Sep 23, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Alkermes Pharma Ireland

EP2445502
Sep 28, 2022Heterocyclic Compounds For The Treatment Of Neurological And Psychological DisordersPatent Maintained As Amended
EP3182958
May 18, 2022Aripiprazole Prodrug CompositionsPatent Maintained As Amended
EP3253377
May 12, 2021Monomethylfumarate Prodrug CompositionsGranted And Under Opposition
EP2970101
Jun 6, 2018Prodrugs Of Fumarates And Their Use In Treating Various DeseasesGranted And Under Opposition
EP2655314
Feb 7, 2018Multi- Api Loading ProdrugsNo Opposition Filed Within Time Limit

Latest oppositions filed by Alkermes Pharma Ireland

Explore patent oppositions filed by Alkermes Pharma Ireland against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 25, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3866765
Injectable Long-Acting Naltrexone Microparticle CompositionsCHONG KUN DANG PHARMACEUTICALNov 6, 2024
EP3566696
Risperidone Sustained Release Microsphere CompositionGENEORA PHARMA SHIJIAZHUANGJul 7, 2021
EP3104844
Complexes Of Sirolimus And Its Derivatives, Process For The Preparation Thereof And Pharmaceutical Compositions Containing ThemDRUGGABILITY HOLDCONov 11, 2020
EP3199146
Risperidone Sustained Release Microsphere CompositionNANJING LUYE PHARMACEUTICALApr 17, 2020
EP2582697
Nanostructured Aprepitant Compositions, Process For The Preparation Thereof And Pharmaceutical Compositions Containing ThemDRUGGABILITY HOLDCO JERSEYJun 27, 2018
EP3010962
Preparation Of Polylactide-Polyglycolide Microparticles Having A Sigmoidal Release ProfilePHARMATHENApr 26, 2018

Latest patents of Alkermes Pharma Ireland opposed by its competitors

Explore Alkermes Pharma Ireland's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2445502
Sep 28, 2022Heterocyclic Compounds For The Treatment Of Neurological And Psychological Disorders1
EP3182958
May 18, 2022Aripiprazole Prodrug Compositions1
EP3253377
May 12, 2021Monomethylfumarate Prodrug Compositions4
EP2970101
Jun 6, 2018Prodrugs Of Fumarates And Their Use In Treating Various Deseases3

Latest PTAB cases involving Alkermes Pharma Ireland

Discover the latest PTAB cases involving Alkermes Pharma Ireland, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 29, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Alkermes Pharma Ireland

IPR2025-00514Jan 30, 2025APOTEXALKERMES PHARMA IRELANDDiscretionary Denial
IPR2018-00943Apr 20, 2018AMNEAL PHARMACEUTICALSALKERMES PHARMA IRELANDTerminated-Settled
IPR2017-00287Nov 17, 2016ALKERMES PHARMA IRELANDOTSUKA PHARMACEUTICALInstitution Denied

Peer Comparison New

IP litigation analysis comparing Alkermes Pharma Ireland with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
ALKERMES PHARMA IRELAND6912Balanced
GENERICS UK211 - - - Highly Aggressive
NANJING LUYE PHARMACEUTICAL - 3 - - Non-Active
SHAN DONG LUYE PHARMACEUTICAL - 3 - - Non-Active